Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
08/2003
08/13/2003EP1334108A1 ARYL PHOSPHATE DERIVATIVES OF d4T
08/13/2003EP1334094A1 Cholesterol lowering benzo[b]thiophenes and benzo[d]isothiazoles
08/13/2003EP1334090A1 Novel bicyclic isoxazolinones as antibacterial agents
08/13/2003EP1333860A1 Antibodies to the propeptide of candida albicans and methods of use
08/13/2003EP1333850A2 Method and composition for inhibition of tumor growth and enhancing an immune response
08/13/2003EP1333848A1 Phyllanthus-derived compounds for the prevention and/or treatment of diseases associated with a retrovirus
08/13/2003EP1333845A1 Treatment of t cell disorders
08/13/2003EP1333841A2 M. tuberculosis chaperonin 10 and uses thereof
08/13/2003EP1333840A2 M. tuberculosis chaperonin 60.1 and uses thereof
08/13/2003EP1333839A1 Method for the treatment of inflammation
08/13/2003EP1333836A2 Cephalosporin antibiotics and prodrugs thereof
08/13/2003EP1333834A2 Antiinflammation agents
08/13/2003EP1333833A2 Novel compounds
08/13/2003EP1333831A2 Aza-and polyaza-naphthalenyl ketones useful as hiv integrase inhibitors
08/13/2003EP1333821A2 Novel uses of combined selective dopamine d2 receptor antagonists and 5-ht1a receptor agonists
08/13/2003EP1333810A2 Oral dosage self-emulsifying formulations of pyranone protease inhibitors
08/13/2003EP1333809A2 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress
08/13/2003EP1333808A2 Electroprocessed composition used in drug delivery and cell encapsulation
08/13/2003EP1333807A2 Extended release erythromycin derivatives
08/13/2003EP1242427B1 Novel piperidine and piperazine derivatives as p2x7 receptor antagonists
08/13/2003EP1222193B1 Imidazole derivatives as phosphodiesterase vii inhibitors
08/13/2003EP1181025B1 Molecular complexes presenting high affinity binding with respect to monocyte derived cells and their uses in therapy
08/13/2003EP1163008B1 Use of trehalose for stabilising a liquid vaccine
08/13/2003EP1158990A4 Administration of an anti-endotoxin drug by intravenous infusion
08/13/2003EP1152768B1 Treatment of chronic viral infections with m. vaccae
08/13/2003EP1147108B1 Substituted nitrogen heterocyclic derivatives and pharmaceutical use thereof
08/13/2003EP1143981A4 Treatment and prevention of hiv and other viral infections
08/13/2003EP1140943B1 Substituted pyrroloindoles
08/13/2003EP0971889B1 Process for synthesizing carbapenem intermediates
08/13/2003EP0859629B1 Phosphorylated recombinant human beta casein for inhibition of attachment of h. influenzae to human cells
08/13/2003EP0837859B1 Tetrahydrofuran antifungals
08/13/2003EP0784470B1 Liposome-formulations for treatment of viral diseases
08/13/2003EP0759755B1 Thiadiazolylalkoxyphenyl derivatives, their preparation and their use anti-picornaviral agents
08/13/2003EP0614374B1 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES
08/13/2003EP0575491B1 Genetically engineered vaccine strain
08/13/2003CN1436196A Pyridine-2-yl-aminoalkyl carbonyl glycyl-beta-alanine and derivs. thereof
08/13/2003CN1436192A HMG-CoA reductase inhibitors and method
08/13/2003CN1436189A Non-nucleoside reverse transcriptase inhibitors
08/13/2003CN1436180A Diamino phenothiazine derivs. and composition comprising same
08/13/2003CN1436174A HMG-CoA reductase inhibitors and their use as medicaments for treatment of cholesterol related diseases
08/13/2003CN1436086A Interferon for treatment of multiple sclerosis
08/13/2003CN1436083A Preparation of pathogen inactivated solution of red blood cells having reduced immunogenicity
08/13/2003CN1436082A 3'-or 2'-hydroxymethyl substd. nucleoside derivs. for treatment of hepatitis virus infections
08/13/2003CN1436079A Imidazopyridine and imidazopyrimidine antiviral agent
08/13/2003CN1436069A Hair oils
08/13/2003CN1435433A Long-acting broad-spectrum chemotactic factor receptor inhibiting matter
08/13/2003CN1435427A Recombinant human alpha-prothymosin interleukin 2 gene and its expression and use
08/13/2003CN1435420A Crystalline form of Adefovir dipivoxil and preparing process thereof
08/13/2003CN1435259A Preparation and use of chronic hepatitis B therapeutic DNA vaccine
08/13/2003CN1435251A ÔÇ£SanhuangÔÇØ drip pill and preparing method thereof
08/13/2003CN1435248A Chinese medicine preparation for treating upper respiratory system diseases, skin infection and pile, and preparing method thereof
08/13/2003CN1435244A Chinese medicine for treating hepatitis B and process for preparing same
08/13/2003CN1435236A Chinese medicine pill for treating cancer and viral hepatitis and producing process thereof
08/13/2003CN1435225A Medical ointment ÔÇ£JiaoxuanxiaoÔÇØ for treating athlete's foot
08/13/2003CN1435210A Skin Chinese medicine disinfectant liquid and use thereof for suppressing prospermia
08/13/2003CN1435200A Medicine for treating hepatitis B
08/13/2003CN1435177A Antibacterial combined medicine
08/13/2003CN1435175A Chinese medicinal preparation contg. lysiontus pauciflorus extract, process for preparing same and use thereof
08/13/2003CN1435174A Externally used urotropin nebula and preparing method thereof
08/13/2003CN1435165A Common cold preventing toothpaste
08/13/2003CN1435095A Synergic microbiocidal composition
08/13/2003CN1117751C Antiviral nucleoside analogues
08/13/2003CN1117585C Nisin in combination with glycerol monolaurate active against helicobacterium
08/13/2003CN1117579C Plaster for treating common cold
08/13/2003CN1117574C Preparation for treating canine distemper
08/13/2003CN1117572C Medicine powder for treating athlete's foot, smelly foot and sweaty foot
08/13/2003CN1117570C Ointment for external use
08/13/2003CN1117558C Compositions contg. antifungal and sulfur compound
08/12/2003US6605713 Contacting D-nucleic acids with a racemic mixture of the target molecule and allow for binding; producing L-nucleic acids; in vitro selection of DNA/RNA with high binding affinity and stability
08/12/2003US6605707 Process for the preparation of 6-O-propargyl erythromycin derivatives
08/12/2003US6605698 Antifungal peptides and composition thereof
08/12/2003US6605666 Polyurethane film-forming dispersions in alcohol-water system
08/12/2003US6605642 Inhibitors of formation of advanced glycation endproducts (AGES)
08/12/2003US6605637 Lipoic acid derivatives, their preparation, and pharmaceutical compositions containing them
08/12/2003US6605634 Aryl and heteroaryl substituted fused pyrrole anti-inflammatory agents
08/12/2003US6605633 Such as 5-Bromo-2-phenyl-1H-indole-3-butanoic acid
08/12/2003US6605630 Active against drug resistant gram positive pathogens
08/12/2003US6605622 Use of anti-estrogenic compounds as anti-fungal agents
08/12/2003US6605614 [1,8] naphthyridine derivatives having antiviral activity
08/12/2003US6605611 Nucleoside and nucleotide analogues labelled with a reporter moiety
08/12/2003US6605609 N-(((5S)-3-(4-(1,1-dioxido-4-thiomorpholinyl)-3,5-difluorophen yl) -2-oxo-1,3-oxazolidin-5-yl)methyl)acetamide antimicrobial used in combination therapy
08/12/2003US6605592 Protein HOFNF53
08/12/2003US6605467 Fusion protein comprising the whole or part of the PP65 protein of human CMV, useable in particular for preparing a vaccine
08/12/2003US6605457 Influenza vaccine
08/12/2003US6605426 Compounds, methods of screening, and in vitro and in vivo uses involving anti-apoptotic genes and anti-apoptotic gene products
08/12/2003US6605301 Dispersible macrolide compounds and method for production thereof
08/12/2003US6605289 Topically administering composition consisting of water, stannous fluoride, and zinc gluconate in amount sufficient to prevent oxidation and hydrolysis of stannous ion for at least three months to animal afflicted with fungal infection
08/12/2003US6605285 Vaccine for protection of poultry against salmonellosis and a process for preparing the same
08/12/2003US6605284 Gene coding for the measles virus mutant antigen
08/12/2003US6605282 Inducing immune response against feline immunodeficiency virus; obtain animal, administer protective agent, detect immunological response against viral infection
08/12/2003US6605069 Catheters comprising quinolone, peptide, macrolide, or aminoglycoside antibiotic or microbiocidal agent homogenously distributed
08/12/2003CA2286126C Pharmaceutical compositions
08/12/2003CA2212836C Substituted isoxazoles for the treatment of inflammation
08/07/2003WO2003064992A2 Novel immunoadhesins for treating and preventing toxicity and pathogen-mediated diseases
08/07/2003WO2003064629A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/07/2003WO2003064626A2 Double-stranded oligonucleotides
08/07/2003WO2003064625A2 Oligonucleotide compositions with enhanced efficiency
08/07/2003WO2003064613A2 Amidases, nucleic acids encoding them and methods for making and using them
08/07/2003WO2003064596A2 Desaturase genes, enzymes encoded thereby, and uses thereof
08/07/2003WO2003064595A2 Recombinant herpesvirus of turkeys and use thereof
1 ... 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 ... 1798